Vion (formerly Oncorx) interesting play on Gene Therapy Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve who wrote (17)	11/21/1996 9:22:00 AM
From: Rob C.	of 370

Steve and All...FYI... Vion Pharmaceuticals, Inc. 4 Science Park New Haven, CT 06511 Tel: 203-498-4210 Fax: 203-498-4211 Contacts: Tom Mizelle, VP Opns, 203-498-4210 E-mail: tmizelle@vionpharm.com NASDAQ symbol: VION About Vion Pharmaceuticals, Inc.: Vion Pharmaceuticals, Inc. (formerly OncoRx, Inc.), is a biopharmaceutical company engaged in the discovery, development and marketing of antiviral and oncology products. Pursuant to license agreements with Yale University the Company has acquired the rights to a number of oncology and antiviral technologies which provide a scientific base for future development of therapeutic products. Vion has a broad research pipeline and is focused on five principal areas of research: Hypoxic Cancer Cell Therapeutics, Alkylating Agent Prodrugs, Ribonucleotide Reductase Inhibitors, Nucleioside Analogs and Gene Therapy. The Company's common stock is traded on the NASDAQ SmallCap Market under the symbol VION. Copyright c 1995 - 1996 Vitadata Corporation. All rights reserved.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next